{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:05:41Z","timestamp":1777295141823,"version":"3.51.4"},"reference-count":113,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.iac.2016.06.010","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T02:16:06Z","timestamp":1475547366000},"page":"765-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Amber","family":"Dahlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott T.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7437","key":"10.1016\/j.iac.2016.06.010_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/bmj.328.7437.434","article-title":"Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice","volume":"328","author":"Jenkins","year":"2004","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.iac.2016.06.010_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/thorax.57.7.569","article-title":"The prevalence of aspirin intolerant asthma (AIA) in Australian asthmatic patients","volume":"57","author":"Vally","year":"2002","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.iac.2016.06.010_bib3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1034\/j.1398-9995.2003.00267.x","article-title":"Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland","volume":"58","author":"Kasper","year":"2003","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11882-009-0023-4","article-title":"Aspirin sensitivity and desensitization for asthma and sinusitis","volume":"9","author":"Stevenson","year":"2009","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ACI.0000000000000021","article-title":"An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease","volume":"14","author":"Choi","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3349\/ymj.2009.50.6.744","article-title":"Update on recent advances in the management of aspirin exacerbated respiratory disease","volume":"50","author":"Palikhe","year":"2009","journal-title":"Yonsei Med J"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.iac.2012.10.003","article-title":"Genetics of hypersensitivity to aspirin and nonsteroidal anti-inflammatory drugs","volume":"33","author":"Kim","year":"2013","journal-title":"Immunol Allergy Clin N Am"},{"issue":"Suppl 2","key":"10.1016\/j.iac.2016.06.010_bib9","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2222.1999.00019.x","article-title":"Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease","volume":"29","author":"Busse","year":"1999","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2165\/00063030-200013010-00004","article-title":"Aspirin-sensitive asthma: recent advances in management","volume":"13","author":"Park","year":"2000","journal-title":"BioDrugs"},{"issue":"6 Suppl 1","key":"10.1016\/j.iac.2016.06.010_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1081-1206(10)62306-X","article-title":"Efficacy of antileukotriene agents in asthma management","volume":"86","author":"Nathan","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.iac.2016.06.010_bib12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","article-title":"The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions","volume":"32","author":"Berges-Gimeno","year":"2002","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 5","key":"10.1016\/j.iac.2016.06.010_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2222.1998.028s5141.x","article-title":"Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma","volume":"28","author":"Dahl\u00e9n","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.iac.2016.06.010_bib14","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0954-6111(96)90015-3","article-title":"Anti-leukotriene intervention: is there adequate information for clinical use in asthma?","volume":"90","author":"Ind","year":"1996","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S1081-1206(10)62084-4","article-title":"The natural history and clinical characteristics of aspirin-exacerbated respiratory disease","volume":"89","author":"Berges-Gimeno","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1172\/JCI620","article-title":"Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma","volume":"101","author":"Cowburn","year":"1998","journal-title":"J\u00a0Clin Invest"},{"issue":"1\u20133","key":"10.1016\/j.iac.2016.06.010_bib17","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000237600","article-title":"Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients","volume":"113","author":"Sampson","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib18","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3346\/jkms.2005.20.6.926","article-title":"Leukotriene-related gene polymorphisms in patients with aspirin-intolerant urticaria and aspirin-intolerant asthma: differing contributions of ALOX5 polymorphism in Korean population","volume":"20","author":"Kim","year":"2005","journal-title":"J\u00a0Korean Med Sci"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1398-9995.2005.00780.x","article-title":"Polymorphism of tandem repeat in promoter of 5-lipoxygenase in ASA-intolerant asthma: a positive association with airway hyperresponsiveness","volume":"60","author":"Kim","year":"2005","journal-title":"Allergy"},{"issue":"19","key":"10.1016\/j.iac.2016.06.010_bib20","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2222.2006.02457.x","article-title":"Cysteinyl leukotriene receptor 1 promoter polymorphism is associated with aspirin-intolerant asthma in males","volume":"36","author":"Kim","year":"2006","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00439-005-1285-0","article-title":"Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma","volume":"117","author":"Akahoshi","year":"2005","journal-title":"Hum Genet"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaci.2005.10.037","article-title":"Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells","volume":"117","author":"Ying","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jaci.2005.02.029","article-title":"Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis","volume":"115","author":"P\u00e9rez-Novo","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib26","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/00016489950181819","article-title":"Arachidonic acid metabolism in nasal tissue and peripheral blood cells in aspirin intolerant asthmatics","volume":"119","author":"Schmid","year":"1999","journal-title":"Acta Otolaryngol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.plefa.2012.09.005","article-title":"Genetic variation in members of the leukotrienes biosynthesis pathway confers risk of ischemic stroke in Eastern Han Chinese","volume":"87","author":"Wang","year":"2012","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5847\/wjem.j.issn.1920-8642.2013.01.006","article-title":"Association of ALOX5, LTA4H and LTC4S gene polymorphisms with ischemic stroke risk in a cohort of Chinese in east China","volume":"4","author":"Wang","year":"2013","journal-title":"World J Emerg Med"},{"key":"10.1016\/j.iac.2016.06.010_bib29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/1742-2094-9-162","article-title":"Association of inflammatory gene polymorphisms with ischemic stroke in a Chinese Han population","volume":"9","author":"Zhao","year":"2012","journal-title":"J\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1164\/rccm.200509-1412OC","article-title":"Influence of leukotriene pathway polymorphisms on response to montelukast in asthma","volume":"173","author":"Lima","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib31","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.arcmed.2012.08.003","article-title":"The -444A\/C polymorphism in the LTC4S gene and the risk of asthma: a meta-analysis","volume":"43","author":"Zhang","year":"2012","journal-title":"Arch Med Res"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/9680","article-title":"Pharmacogenetic association between\u00a0ALOX5 promoter genotype and the response to anti-asthma treatment","volume":"22","author":"Drazen","year":"1999","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3349\/ymj.2006.47.1.15","article-title":"Genetic markers for differentiating aspirin-hypersensitivity","volume":"47","author":"Kim","year":"2006","journal-title":"Yonsei Med J"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/FPC.0b013e3280120043","article-title":"Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast","volume":"17","author":"Klotsman","year":"2007","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03256228","article-title":"Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers","volume":"11","author":"Lima","year":"2007","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/FPC.0b013e328326e0b1","article-title":"5-lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci","volume":"19","author":"Tantisira","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.iac.2012.11.006","article-title":"Pathogenesis of aspirin-exacerbated respiratory disease and reactions","volume":"33","author":"Laidlaw","year":"2013","journal-title":"Immunol Allergy Clin N Am"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib38","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.02.005","article-title":"Platelets in patients with aspirin-exacerbated respiratory disease","volume":"135","author":"Laidlaw","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2016.06.010_bib39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/gerona\/glt179","article-title":"Variants of asthma and chronic obstructive pulmonary disease genes and lung function decline in aging","volume":"69","author":"Poon","year":"2014","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/ng1256","article-title":"Positional cloning of a novel gene influencing asthma from chromosome 2q14","volume":"35","author":"Allen","year":"2003","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib41","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.anai.2014.12.003","article-title":"Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype","volume":"114","author":"Kim","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"10","key":"10.1016\/j.iac.2016.06.010_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/01902148.2014.927939","article-title":"Association analysis of FABP1 gene polymorphisms with aspirin-exacerbated respiratory disease in asthma","volume":"40","author":"Chang","year":"2014","journal-title":"Exp Lung Res"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2500\/ajra.2015.29.4123","article-title":"Factors driving the aspirin exacerbated respiratory disease phenotype","volume":"29","author":"Steinke","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"7","key":"10.1016\/j.iac.2016.06.010_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/014556130708600715","article-title":"The prevalence of Samter's triad in patients undergoing functional endoscopic sinus surgery","volume":"86","author":"Kim","year":"2007","journal-title":"Ear Nose Throat J"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib45","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/MLG.0b013e3180333121","article-title":"Impact of aspirin intolerance on outcomes of sinus surgery","volume":"117","author":"Robinson","year":"2007","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.iac.2016.06.010_bib46","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/MLG.0b013e318170af1e","article-title":"Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma?","volume":"118","author":"Awad","year":"2008","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1164\/rccm.201412-2278OC","article-title":"Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease","volume":"192","author":"Stevens","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib48","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3892\/mmr.2012.1251","article-title":"Genetic association analysis of CIITA variations with nasal polyp pathogenesis in asthmatic patients","volume":"7","author":"Bae","year":"2013","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib49","first-page":"166","article-title":"Eicosanoids from biopsy of normal and polypous nasal mucosa","volume":"34","author":"Baenkler","year":"1996","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib50","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2332\/allergolint.O-08-545","article-title":"Correlation between the prostaglandin D(2)\/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma","volume":"57","author":"Yoshimura","year":"2008","journal-title":"Allergol Int"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.1979","article-title":"Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma","volume":"209","author":"Adamjee","year":"2006","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib52","first-page":"331","article-title":"Genetic association study in nasal polyposis","volume":"22","author":"Benito Pescador","year":"2012","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/thx.2006.057935","article-title":"Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels","volume":"62","author":"Batra","year":"2007","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.iac.2016.06.010_bib54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.4161\/epi.6.9.16061","article-title":"Epigenetic changes in B lymphocytes associated with house dust mite allergic asthma","volume":"6","author":"Pascual","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.iac.2016.06.010_bib55","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1038\/emm.2013.24","article-title":"A\u00a0genetic effect of IL-5 receptor \u03b1 polymorphism in patients with aspirin-exacerbated respiratory disease","volume":"45","author":"Losol","year":"2013","journal-title":"Exp Mol Med"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib56","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaci.2009.04.003","article-title":"Development and function of TH17 cells in health and disease","volume":"123","author":"Louten","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib57","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaci.2004.10.019","article-title":"IL-17 cytokine family","volume":"114","author":"Kawaguchi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib58","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.08-1595","article-title":"Association of IL-17RB gene polymorphism with asthma","volume":"135","author":"Jung","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib59","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.humimm.2012.11.002","article-title":"Association of single nucleotide polymorphisms on Interleukin 17 receptor A (IL17RA) gene with aspirin hypersensitivity in asthmatics","volume":"74","author":"Park","year":"2013","journal-title":"Hum Immunol"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib60","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1365-2222.1997.tb00747.x","article-title":"Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes","volume":"27","author":"Dekker","year":"1997","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib61","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jaci.2003.12.012","article-title":"HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population","volume":"113","author":"Choi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib62","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jaci.2004.05.051","article-title":"The HLA-DPB1*0301 marker might predict the requirement for leukotriene receptor antagonist in patients with aspirin-intolerant asthma","volume":"114","author":"Park","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib63","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.2500\/ajra.2015.29.4154","article-title":"HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease","volume":"29","author":"Esmaeilzadeh","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib64","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2013.05.008","article-title":"Prominent role of IFN-\u03b3 in patients with aspirin-exacerbated respiratory disease","volume":"132","author":"Steinke","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib65","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1165\/rcmb.2006-0252OC","article-title":"Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells","volume":"36","author":"Early","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1089\/dna.2013.2213","article-title":"Association analysis of member RAS oncogene family gene polymorphisms with aspirin intolerance in asthmatic patients","volume":"33","author":"Park","year":"2014","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.iac.2016.06.010_bib67","first-page":"365769","article-title":"The Interplay between ROS and Ras GTPases: Physiological and Pathological Implications","volume":"2012","author":"Ferro","year":"2012","journal-title":"J\u00a0Signal Transduct"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib68","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2222.1998.00251.x","article-title":"Heat shock protein 70 upregulation is related to HLA-DR expression in bronchial asthma. Effects of inhaled glucocorticoids","volume":"28","author":"Bertorelli","year":"1998","journal-title":"Clin Exp Allergy"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib70","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1165\/ajrcmb.13.6.7576706","article-title":"Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis","volume":"13","author":"Vignola","year":"1995","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib71","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2310\/JIM.0b013e3182857d6c","article-title":"Heat shock protein 70 gene polymorphisms in Japanese patients with aspirin-exacerbated respiratory disease","volume":"61","author":"Kikuchi","year":"2013","journal-title":"J\u00a0Investig Med"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/BF00187095","article-title":"Structure and expression of the three MHC-linked HSP70 genes","volume":"32","author":"Milner","year":"1990","journal-title":"Immunogenetics"},{"issue":"12","key":"10.1016\/j.iac.2016.06.010_bib73","doi-asserted-by":"crossref","first-page":"e111220","DOI":"10.1371\/journal.pone.0111220","article-title":"The SNP rs3128965 of HLA-DPB1 as a genetic marker of the AERD phenotype","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00439-012-1247-2","article-title":"Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean population","volume":"132","author":"Park","year":"2013","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib75","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12931-015-0305-4","article-title":"The whole-genome expression analysis of peripheral blood mononuclear cells from aspirin sensitive asthmatics versus aspirin tolerant patients and healthy donors after in\u00a0vitro aspirin challenge","volume":"16","author":"Wieczfinska","year":"2015","journal-title":"Respir Res"},{"issue":"11","key":"10.1016\/j.iac.2016.06.010_bib76","doi-asserted-by":"crossref","first-page":"e111887","DOI":"10.1371\/journal.pone.0111887","article-title":"Exonic variants associated with development of aspirin exacerbated respiratory diseases","volume":"9","author":"Shin","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.iac.2016.06.010_bib77","doi-asserted-by":"crossref","first-page":"e13818","DOI":"10.1371\/journal.pone.0013818","article-title":"Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma","volume":"5","author":"Kim","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib78","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2796.2007.01809.x","article-title":"The origins of the developmental origins theory","volume":"261","author":"Barker","year":"2007","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib79","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1398-9995.2010.02514.x","article-title":"Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics","volume":"66","author":"Cheong","year":"2011","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib80","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1165\/rcmb.2014-0486OC","article-title":"Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease","volume":"54","author":"Cahill","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib81","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaci.2011.01.065","article-title":"Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma","volume":"128","author":"Roca-Ferrer","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.010_bib82","first-page":"265","article-title":"Biosynthesis and metabolism of leukotrienes","volume":"18","author":"Hammarstr\u00f6m","year":"1983","journal-title":"Monogr Allergy"},{"key":"10.1016\/j.iac.2016.06.010_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.bi.52.070183.002035","article-title":"Leukotrienes","volume":"52","author":"Hammarstr\u00f6m","year":"1983","journal-title":"Annu Rev Biochem"},{"issue":"1\u20132","key":"10.1016\/j.iac.2016.06.010_bib84","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mce.2006.03.038","article-title":"The 5 lipoxygenase system in the vasculature: emerging role in health and disease","volume":"252","author":"Osher","year":"2006","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib85","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.bmb.a072183","article-title":"Prostaglandins and leukotrienes as inflammatory mediators","volume":"43","author":"Salmon","year":"1987","journal-title":"Br Med Bull"},{"issue":"1\u20132","key":"10.1016\/j.iac.2016.06.010_bib86","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10787-006-1496-6","article-title":"The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?","volume":"14","author":"Sharma","year":"2006","journal-title":"Inflammopharmacology"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib87","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1398-9995.2009.02015.x","article-title":"Leukotriene pathway genetics and pharmacogenetics in allergy","volume":"64","author":"Duroudier","year":"2009","journal-title":"Allergy"},{"issue":"6 Pt 1","key":"10.1016\/j.iac.2016.06.010_bib88","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"issue":"5 Pt 1","key":"10.1016\/j.iac.2016.06.010_bib89","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4168\/aair.2011.3.1.3","article-title":"Aspirin-exacerbated respiratory disease: evaluation and management","volume":"3","author":"Lee","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0091-6749(72)90014-0","article-title":"Aspirin intolerance in asthma. Detection by oral challenge","volume":"50","author":"McDonald","year":"1972","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib92","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2222.1976.tb01896.x","article-title":"The diagnosis of aspirin idiosyncrasy by analgesic challenge","volume":"6","author":"Delaney","year":"1976","journal-title":"Clin Allergy"},{"issue":"11","key":"10.1016\/j.iac.2016.06.010_bib93","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1365-2362.1992.tb01437.x","article-title":"Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy","volume":"22","author":"Pacheco","year":"1992","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.iac.2016.06.010_bib94","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1398-9995.2008.01667.x","article-title":"The role of LTA4H and ALOX5AP polymorphism in asthma and allergy susceptibility","volume":"63","author":"Holloway","year":"2008","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib95","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jaci.2010.06.048","article-title":"ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos","volume":"126","author":"Tcheurekdjian","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib96","first-page":"582","article-title":"The role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos","volume":"40","author":"Via","year":"2010","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib97","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/MCP.0b013e32831da8be","article-title":"Pharmacogenetics of asthma","volume":"15","author":"Lima","year":"2009","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib98","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s100380200018","article-title":"Identification of 779 genetic variations in eight\u00a0genes encoding members of the ATP-binding cassette, subfamily C (ABCC\/MRP\/CFTR","volume":"47","author":"Saito","year":"2002","journal-title":"J\u00a0Hum Genet"},{"issue":"3","key":"10.1016\/j.iac.2016.06.010_bib99","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/dmd.106.012765","article-title":"Inhibition of MRP1\/ABCC1, MRP2\/ABCC2, and MRP3\/ABCC3 by nucleoside, nucleotide, and non-nucleoside reverse transcriptase inhibitors","volume":"35","author":"Weiss","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/FPC.0b013e32831bd98c","article-title":"Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response","volume":"19","author":"Mougey","year":"2009","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"10.1016\/j.iac.2016.06.010_bib101","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/tpj.2015.34","article-title":"Genome-wide association study of leukotriene modifier response in asthma","volume":"16","author":"Dahlin","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib102","doi-asserted-by":"crossref","first-page":"e0129385","DOI":"10.1371\/journal.pone.0129385","article-title":"Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma","volume":"10","author":"Dahlin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.iac.2016.06.010_bib103","first-page":"794890","article-title":"Genetic mechanisms in aspirin-exacerbated respiratory disease","volume":"2012","author":"Shrestha Palikhe","year":"2012","journal-title":"J\u00a0Allergy (Cairo)"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib104","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.anai.2010.10.021","article-title":"Association analysis of RGS7BP gene polymorphisms with aspirin intolerance in asthmatic patients","volume":"106","author":"Lee","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2217\/pgs.14.2","article-title":"Clinical course of patients with aspirin-exacerbated respiratory disease: can we predict the prognosis?","volume":"15","author":"Kim","year":"2014","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.iac.2016.06.010_bib106","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000324463","article-title":"Arg16Gly \u03b22-adrenergic receptor gene polymorphism in Japanese patients with aspirin-exacerbated respiratory disease","volume":"156","author":"Kohyama","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"issue":"9","key":"10.1016\/j.iac.2016.06.010_bib107","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1124\/dmd.111.039065","article-title":"Evaluation of CYP2C8 inhibition in\u00a0vitro: utility of montelukast as a selective CYP2C8 probe substrate","volume":"39","author":"VandenBrink","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.iac.2016.06.010_bib108","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1124\/dmd.31.11.1352","article-title":"Mechanism-based inhibition of human liver microsomal cytochrome P450 1A2 by zileuton, a 5-lipoxygenase inhibitor","volume":"31","author":"Lu","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1016\/j.iac.2016.06.010_bib109","first-page":"1163","article-title":"Identification of the human liver cytochrome P450 enzymes involved in the metabolism of zileuton (ABT-077) and its N-dehydroxylated metabolite, Abbott-66193","volume":"23","author":"Machinist","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.iac.2016.06.010_bib110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00228-011-1158-5","article-title":"Fluconazole but not the CYP3A4 inhibitor, itraconazole, increases zafirlukast plasma concentrations","volume":"68","author":"Karonen","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.iac.2016.06.010_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00130832-200102000-00006","article-title":"Aspirin-induced rhinitis and asthma","volume":"1","author":"Szczeklik","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2016.06.010_bib112","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1089\/dna.2012.1688","article-title":"A\u00a0highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study","volume":"31","author":"Shin","year":"2012","journal-title":"DNA Cell Biol"},{"issue":"6","key":"10.1016\/j.iac.2016.06.010_bib113","doi-asserted-by":"crossref","first-page":"e66644","DOI":"10.1371\/journal.pone.0066644","article-title":"Elevation of eosinophil-derived neurotoxin in plasma of the subjects with aspirin-exacerbated respiratory disease: a possible peripheral blood protein biomarker","volume":"8","author":"Shin","year":"2013","journal-title":"PLoS One"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T16:46:31Z","timestamp":1657385191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0889856116300558"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.010","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic and Epigenetic Components of Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}